Pancreatic enzyme replacement therapy in cystic fibrosis: dose, variability and coefficient of fat absorption
Objectives: Pancreatic enzyme replacement therapy (PERT) remains a backbone in the nutritional treatment of cystic fibrosis. Currently, there is a lack of an evidence-based tool that allows dose adjustment. To date, no studies have found an association between PERT dose and fat absorption. Therefore...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Aran Ediciones
|
Series: | Revista Espanola de Enfermedades Digestivas |
Subjects: | |
Online Access: | http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1130-01082017001000003&lng=en&tlng=en |